Literature DB >> 3033092

Detection of antigen to herpes simplex virus in cerebrospinal fluid from patients with herpes simplex encephalitis.

F D Lakeman, J Koga, R J Whitley.   

Abstract

Cerebrospinal fluid (CSF) specimens were obtained from patients with presumed herpes simplex encephalitis who underwent brain biopsy for diagnostic confirmation. Coded CSF specimens were fixed on nitrocellulose filter paper and probed with a pool of monoclonal antibodies directed against four herpes simplex virus glycoproteins (gB, gC, gD, and gE). Herpes simplex virus antigen was detected in 35 of 40 specimens obtained from 26 biopsy-positive patients. In contrast, only three of 25 specimens from 17 biopsy-negative patients gave positive results by this assay. An additional 30 CSF specimens from patients with proven bacterial and fungal infections were all negative by this assay. For all specimens tested, the sensitivity and specificity of the assay were both 88%. However, when results were evaluated by patient, the sensitivity was 92% (24 of 26) with a specificity of 82% (14 of 17). Among specimens collected one week or later after disease onset, the sensitivity was 100%, with a specificity of 93%.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033092     DOI: 10.1093/infdis/155.6.1172

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

Review 1.  Herpes simplex virus infections of the central nervous system. Encephalitis and neonatal herpes.

Authors:  R J Whitley
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

2.  Brain biopsy in the management of focal encephalitis.

Authors:  N E Anderson; E W Willoughby; B J Synek; M C Croxson; G L Glasgow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

3.  Amplification and characterization of herpesvirus DNA in cerebrospinal fluid from patients with acute encephalitis.

Authors:  F Rozenberg; P Lebon
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

4.  Unusual course of herpes simplex virus encephalitis after acyclovir therapy.

Authors:  W Preiser; B Weber; G Klös; P A Fischer; H W Doerr
Journal:  Infection       Date:  1996 Sep-Oct       Impact factor: 3.553

Review 5.  The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Cinque; G M Cleator; T Weber; P Monteyne; C J Sindic; A M van Loon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

6.  Diagnosis of herpes simplex virus encephalitis by detection of virus-specific immunoglobulins A and G in serum and cerebrospinal fluid by using an antibody-capture enzyme-linked immunosorbent assay.

Authors:  A M van Loon; J T van der Logt; F W Heessen; B Postma; M F Peeters
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

7.  Herpes simplex virus type 2 encephalitis and concomitant cytomegalovirus infection in a patient with AIDS: detection of virus-specific DNA in CSF by nested polymerase chain reaction.

Authors:  R F Miller; J D Fox; J C Waite; A Severn; N S Brink
Journal:  Genitourin Med       Date:  1995-08

8.  Cognitive impairment after acute encephalitis: comparison of herpes simplex and other aetiologies.

Authors:  L Hokkanen; E Poutiainen; L Valanne; O Salonen; M Iivanainen; J Launes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

9.  A polymerase chain reaction assay of cerebrospinal fluid in patients with suspected herpes simplex encephalitis.

Authors:  N E Anderson; K F Powell; M C Croxson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

10.  CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  M Schmidt-Hieber; G Silling; E Schalk; W Heinz; J Panse; O Penack; M Christopeit; D Buchheidt; U Meyding-Lamadé; S Hähnel; H H Wolf; M Ruhnke; S Schwartz; G Maschmeyer
Journal:  Ann Oncol       Date:  2016-04-06       Impact factor: 32.976

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.